Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.
By S. Hollon, Robert J. DeRubeis, R. Shelton, J. Amsterdam, R. Salomon, J. O'reardon, M. L. Lovett, P. R. Young, Kirsten L. Haman, Brent B. Freeman and 1 more. Archives of General Psychiatry, 2005
730 citations recorded by the source corpus.
Subfields: Experimental and Cognitive Psychology, Pharmacology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/342a502c1ea9a06656ec025b9fddfdae4e95318e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Experimental and Cognitive Psychology
- Robert J. DeRubeis
- A. Beck
- A. Chiesa
- Thomas Richardson
- Jan M. Burg
- Alessandro Serretti
- Andrew C. Butler
- R. Shelton
In Pharmacology
- Robert J. DeRubeis
- Thomas Richardson
- A. Beck
- Derek Richards
- Alessandro Serretti
- R. Shelton
- S. Gilbody
- A. Chiesa
In Psychiatry and Mental health
- Robert J. DeRubeis
- Jason E. Chapman
- A. Beck
- Derek Richards
- Andrew C. Butler
- Evan M. Forman
- S. Gilbody
- A. Chiesa
Citations in the corpus
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders (2015, background): “Time to respond to treatment is shown to be longer with psychological treatment than pharmacological treatment (Hollon et al., 2005b).”
- The efficacy of psychodynamic psychotherapy. (2010, methodology): “Leichsenring (2001) noted that both treatments appeared to qualify as empirically supported therapies according to the criteria specified by the American Psychological Association’s Division 12 Task Force on Promotion and Dissemination of Psychological Procedures (1995; Chambless et al., 1998).”
- Computer-based psychological treatments for depression: a systematic review and meta-analysis. (2012, background): “Perhaps interventions with booster sessions may be of use to maintain improvements (Hollon et al., 2005).”
- Mindfulness based cognitive therapy for psychiatric disorders: a systematic review and meta-analysis. (2011, background): “…and/or pharmacological treatments suchas cognitive psychotherapy orADmedications, patients who have experienced an MD episode carry a risk for relapse over the period of 1 year as high as 30-70% depending on prior and current therapeutic strategies (e.g (Ramana et al., 1995; Hollon et al., 2005).”
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines (2015, background): “76%, NNT 2–3); patients compliant with continuation antidepressants had a 42% relapse rate (Hollon et al., 2005).”
- Cognitive therapy vs. medications for depression: Treatment outcomes and neural mechanisms (2008, methodology): “In the continuation phase of the recent CT versus ADM study, patients who responded to 16 weeks of ADM were randomly assigned to either continue the treatment or change to a (pill) placebo conditio”
- The empirical status of cognitive-behavioral therapy: a review of meta-analyses. (2006, background): “Recently , a large multi - site clinical trial found that cognitive therapy had an enduring effect for moderate - to - severely depressed patients that extended beyond the end of treatment and was equivalent to the effect of keeping patients on antidepressant medication ( see Hollon et al .”
- Don't Forget Your Body: Mindfulness, Embodiment, and the Treatment of Depression (2012, background): “One of the most striking difficulties in the treatment of depression is that chronic and recurring types of depression are common phenomena (Hollon et al. 2005; Vittengl et al. 2007).”
- Cognitive therapy vs medications in the treatment of moderate to severe depression. (2005, methodology): “Thus, over the 16-week treatment course, attrition rate was 16% for the ADM cell and 15% for CT. Attrition did not differ significantly between sites or across conditions after 8 weeks or after 16 weeks.”
- The Personalized Advantage Index: Translating Research on Prediction into Individualized Treatment Recommendations. A Demonstration (2014, methodology): “The sampling method and outcomes have been described elsewhere [16,17].”
- the ChemiCal imbalanCe explanation of Depression: reDuCing blame at What Cost? (2009, background): “such an explanation is at odds with research indicating that depression may be caused by a combination of biological, environmental, and psychosocial factors (national institute of mental health, 2001), as well as evidence that psychological treatments like cognitive-behavior therapy are as effectiv”